Takehide Fujimoto

1.6k total citations · 1 hit paper
30 papers, 1.2k citations indexed

About

Takehide Fujimoto is a scholar working on Epidemiology, Surgery and Genetics. According to data from OpenAlex, Takehide Fujimoto has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Surgery and 7 papers in Genetics. Recurrent topics in Takehide Fujimoto's work include Inflammatory Bowel Disease (5 papers), Gut microbiota and health (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Takehide Fujimoto is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Gut microbiota and health (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Takehide Fujimoto collaborates with scholars based in Japan. Takehide Fujimoto's co-authors include Akira Andoh, Hirotsugu Imaeda, Kenichiro Takahashi, Shigeki Bamba, Yoshihide Fujiyama, Osamu Inatomi, Atsushi Nishida, Eiji Kasumi, Mitsushige Sugimoto and Makoto Shioya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Medicine.

In The Last Decade

Takehide Fujimoto

30 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease

2016 460 citations Kenichiro Takahashi, Atsushi Nishida et al. Digestion profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takehide Fujimoto Japan	13	628	380	270	236	215	30	1.2k
Akihiko Oka Japan	22	514 0.8×	345 0.9×	306 1.1×	276 1.2×	201 0.9×	76	1.4k
Marijn C. Visschedijk Netherlands	15	656 1.0×	573 1.5×	348 1.3×	205 0.9×	195 0.9×	53	1.3k
Shabnam Shahrokh Iran	22	529 0.8×	317 0.8×	258 1.0×	163 0.7×	262 1.2×	93	1.2k
Neil E. McCarthy United Kingdom	18	666 1.1×	521 1.4×	279 1.0×	398 1.7×	181 0.8×	40	1.5k
Christopher D. Packey United States	9	767 1.2×	270 0.7×	185 0.7×	159 0.7×	256 1.2×	17	1.2k
Roberto Ferrarese Italy	19	880 1.4×	224 0.6×	237 0.9×	216 0.9×	279 1.3×	36	1.6k
Charlotte Hedin Sweden	21	848 1.4×	716 1.9×	358 1.3×	397 1.7×	252 1.2×	58	1.8k
Ulrich Böcker Germany	19	381 0.6×	312 0.8×	324 1.2×	290 1.2×	87 0.4×	36	1.2k
Julia Manasson United States	13	898 1.4×	245 0.6×	214 0.8×	389 1.6×	247 1.1×	16	1.6k
Chenggong Yu China	18	879 1.4×	208 0.5×	124 0.5×	134 0.6×	243 1.1×	33	1.4k

Countries citing papers authored by Takehide Fujimoto

Since Specialization

Citations

This map shows the geographic impact of Takehide Fujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehide Fujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehide Fujimoto more than expected).

Fields of papers citing papers by Takehide Fujimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehide Fujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehide Fujimoto. The network helps show where Takehide Fujimoto may publish in the future.

Co-authorship network of co-authors of Takehide Fujimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Takehide Fujimoto. A scholar is included among the top collaborators of Takehide Fujimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehide Fujimoto. Takehide Fujimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inatomi, Osamu, Shigeki Bamba, Takayuki Imai, et al.. (2023). Bile duct penetrating duodenal wall sign: a novel computed tomography finding of common bile duct stone impaction into duodenal major papilla. Japanese Journal of Radiology. 41(8). 854–862. 1 indexed citations

Sonoda, Akinaga, et al.. (2022). Bleeding anorectal varices treated by a direct puncture approach through the greater sciatic foramen: The utility of a steerable microcatheter for reverse catheterization. SHILAP Revista de lepidopterología. 17(4). 1104–1109. 1 indexed citations

Inatomi, Osamu, Hiroshi Matsumoto, Takehide Fujimoto, et al.. (2021). Utility and safety of a new uneven double-lumen sphincterotome in cases of difficult biliary cannulation. BMC Gastroenterology. 21(1). 102–102. 1 indexed citations

Noda, Satoshi, Hiroya Iida, Takehide Fujimoto, et al.. (2021). Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 88(2). 281–288. 14 indexed citations

Iida, Hiroya, Satoshi Noda, Takehide Fujimoto, et al.. (2021). A useful case of tumor resection and monitoring the blood concentration at lenvatinib therapy for multiple hepatocellular carcinoma. Kanzo. 62(2). 80–88. 1 indexed citations

Noda, Satoshi, Daiki Hira, Takehide Fujimoto, et al.. (2020). Sorafenib exposure and its correlation with response and safety in advanced hepatocellular carcinoma: results from an observational retrospective study. Cancer Chemotherapy and Pharmacology. 86(1). 129–139. 12 indexed citations

Inatomi, Osamu, Takayuki Imai, Takehide Fujimoto, et al.. (2018). Dexmedetomidine is safe and reduces the additional dose of midazolam for sedation during endoscopic retrograde cholangiopancreatography in very elderly patients. BMC Gastroenterology. 18(1). 166–166. 34 indexed citations

Bamba, Shigeki, Kenichiro Takahashi, Masaki Murata, et al.. (2018). Efficacy and safety of cold forceps polypectomy utilizing the jumbo cup: a prospective study. Intestinal Research. 17(2). 265–272. 8 indexed citations

Nishida, Atsushi, Osamu Inatomi, Takehide Fujimoto, et al.. (2017). Interleukin-36α Induces Inflammatory Mediators From Human Pancreatic Myofibroblasts Via a MyD88 Dependent Pathway. Pancreas. 46(4). 539–548. 23 indexed citations

10.

Takahashi, Kenichiro, Atsushi Nishida, Takehide Fujimoto, et al.. (2016). Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease. Digestion. 93(1). 59–65. 460 indexed citations breakdown →

11.

Takahashi, Kenichiro, Takehide Fujimoto, Makoto Shioya, et al.. (2015). A case of Crohn’s disease that developed anti-infliximab and anti-adalimumab antibodies. Clinical Journal of Gastroenterology. 8(2). 88–91. 1 indexed citations

12.

Fujimoto, Takehide, Hirotsugu Imaeda, Kenichiro Takahashi, et al.. (2015). Eotaxin-3 (CCL26) Expression in Human Pancreatic Myofibroblasts. Pancreas. 45(3). 420–424. 9 indexed citations

13.

Imaeda, Hirotsugu, Shigeki Bamba, Kenichiro Takahashi, et al.. (2013). Relationship between serum infliximab trough levels and endoscopic activities in patients with Crohn’s disease under scheduled maintenance treatment. Journal of Gastroenterology. 49(4). 674–682. 85 indexed citations

14.

Imaeda, Hirotsugu, Kenichiro Takahashi, Takehide Fujimoto, et al.. (2013). Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn’s disease. Journal of Gastroenterology. 49(1). 100–109. 72 indexed citations

15.

Aomatsu, Tomoki, Hirotsugu Imaeda, Takehide Fujimoto, et al.. (2012). Terminal Restriction Fragment Length Polymorphism Analysis of the Gut Microbiota Profiles of Pediatric Patients with Inflammatory Bowel Disease. Digestion. 86(2). 129–135. 24 indexed citations

16.

Aomatsu, Tomoki, Hirotsugu Imaeda, Kenichiro Takahashi, et al.. (2012). Tacrolimus (FK506) suppresses TNF-α-induced CCL2 (MCP-1) and CXCL10 (IP-10) expression via the inhibition of p38 MAP kinase activation in human colonic myofibroblasts. International Journal of Molecular Medicine. 30(5). 1152–1158. 24 indexed citations

17.

Imaeda, Hirotsugu, Takehide Fujimoto, Kenichiro Takahashi, et al.. (2012). Terminal-Restriction Fragment Length Polymorphism (T-RFLP) Analysis for Changes in the Gut Microbiota Profiles of Indomethacin- and Rebamipide-Treated Mice. Digestion. 86(3). 250–257. 19 indexed citations

18.

Aomatsu, Tomoki, Hirotsugu Imaeda, Kenichiro Takahashi, et al.. (2012). Neutralization of complement component C5 ameliorates the development of dextran sulfate sodium (DSS)-colitis in mice. Journal of Clinical Biochemistry and Nutrition. 52(1). 72–75. 7 indexed citations

19.

Imaeda, Hirotsugu, et al.. (2012). Polymorphisms of the Niemann-Pick C1-like 1 gene in a Japanese population. Biomedical Reports. 1(1). 156–160. 7 indexed citations

20.

Imagawa, Atsushi, Yoshiro Kawahara, Haruo Matsushita, et al.. (2008). Satisfaction with bispectral index monitoring of propofol-mediated sedation during endoscopic submucosal dissection: a prospective, randomized study. Endoscopy. 40(11). 905–909. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact